Professor, Pediatrics, University of Minnesota Medical School
Medical Genetics
Dr. Susan A. Berry, MD
|
|
Give Review
Dr. Susan A. Berry practices Medical Genetics. He attended University of Kansas School of Medicine. He received 1 awards: "Super Doctor". Susan Berry is also published. He has 82 publications published. The lastest publication: "Increased placental iron regulatory protein-1 expression in diabetic pregnancies complicated by fetal iron deficiency.'
Publications
- Outcomes of four patients with homocysteine remethylation disorders detected by newborn screening.
- Lack of IL7Rα expression in T cells is a hallmark of T-cell immunodeficiency in Schimke immuno-osseous dysplasia (SIOD).
- Returning a Research Participant's Genomic Results to Relatives: Analysis and Recommendations.
- Blood ammonia and glutamine as predictors of hyperammonemic crises in patients with urea cycle disorder.
- Glycerol phenylbutyrate treatment in children with urea cycle disorders: Pooled analysis of short and long-term ammonia control and outcomes.
- Parental Permission for Pilot Newborn Screening Research: Guidelines From the NBSTRN.
- Phenylalanine hydroxylase deficiency: diagnosis and management guideline.
- Elevated phenylacetic acid levels do not correlate with adverse events in patients with urea cycle disorders or hepatic encephalopathy and can be predicted based on th...
- Population pharmacokinetic modeling and dosing simulations of nitrogen-scavenging compounds: disposition of glycerol phenylbutyrate and sodium phenylbutyrate in adult ...
- Insurance coverage of medical foods for treatment of inherited metabolic disorders.
- Newborn screening 50 years later: access issues faced by adults with PKU.
- Ammonia Control in Children Ages 2 Months through 5 Years with Urea Cycle Disorders: Comparison of Sodium Phenylbutyrate and Glycerol Phenylbutyrate.
- The quality of metabolic newborn screening specialty care services: results of a survey of primary care providers.
- Evaluation of newborn screening bloodspot-based genetic testing as second tier screen for bedside newborn hearing screening.
- Deletion and duplication of 11p13-11p14: Reciprocal aberrations derived from a paternal insertion.
- What questions should newborn screening long-term follow-up be able to answer? A statement of the US Secretary for Health and Human Services' Advisory Committee on Her...
- Long-term follow-up of newborn screening patients.
- A novel microdeletion/microduplication syndrome of 19p13.13.
- Phase 2 comparison of a novel ammonia scavenging agent with sodium phenylbutyrate in patients with urea cycle disorders: safety, pharmacokinetics and ammonia control.
- Severe methylenetetrahydrofolate reductase (MTHFR) deficiency: a case report of nonclassical homocystinuria.
- Survival after treatment with phenylacetate and benzoate for urea-cycle disorders.
- Expanded newborn screening identifies maternal primary carnitine deficiency.
- Increased MECP2 gene copy number as the result of genomic duplication in neurodevelopmentally delayed males.
- Newborn blood spot screening and genetic services: a survey of Minnesota primary care physicians.
- A common mutation is associated with a mild, potentially asymptomatic phenotype in patients with isovaleric acidemia diagnosed by newborn screening.
- Ophthalmic manifestations of Wolf-Hirschhorn syndrome.
- Prospective diagnosis of 2-methylbutyryl-CoA dehydrogenase deficiency in the Hmong population by newborn screening using tandem mass spectrometry.
- Ten novel FBN2 mutations in congenital contractural arachnodactyly: delineation of the molecular pathogenesis and clinical phenotype.
- 3-Hydroxyisovalerylcarnitine in patients with deficiency of 3-methylcrotonyl CoA carboxylase.
- Impact of a school health coordinator intervention on health-related school policies and student behavior.
- Ontogeny and pituitary regulation of testicular growth hormone-releasing hormone-like messenger ribonucleic acid.
- A case of Satoyoshi syndrome: a multisystem disorder.
- Achievement of glycemic outcome goals in pediatric diabetes: the impact of staff number.
- Metabolic effects of rexinoids: tissue-specific regulation of lipoprotein lipase activity.
- Hepatic fatty acid-binding protein mRNA is regulated by growth hormone.
- Medical genetics for clinicians. 2. Prenatal diagnosis, teratogens, oncogenes.
- Medical genetics for clinicians. 1. Recent advances in diagnostic technology.
- Two siblings with biotin-resistant 3-methylcrotonyl-coenzyme A carboxylase deficiency.
- Effects of elevated serum insulinlike growth factor-II on growth hormone and insulinlike growth factor-I mRNA and secretion.
- Spontaneous hair hyperpigmentation in response to vitamin intake in pregnancy--a clue for homocystinuria.
- The oculocerebrocutaneous (Delleman) syndrome.
- Increased placental iron regulatory protein-1 expression in diabetic pregnancies complicated by fetal iron deficiency.
- Olanzapine safety and efficacy in patients with borderline personality disorder and comorbid dysthymia.
- Developmental regulation of the hepatic acute phase response.
- Growth hormone-releasing hormone-like messenger ribonucleic acid and immunoreactive peptide are present in human testis and placenta.
- Discoordinate hormonal and ontogenetic regulation of four rat serpin genes.
- An inducible nuclear factor binds to a growth hormone-regulated gene.
- Hormonal regulation of serum alpha 1-antitrypsin and hepatic alpha 1-antitrypsin mRNA in rats.
- Identification of a rat GHRH-like substance and its messenger RNA in rat testis.
- Growth failure in cholestatic rats: the effect of malnutrition on insulin-like growth factor I.
- Binding of a growth hormone-inducible nuclear factor is mediated by tyrosine phosphorylation.
- Expression of growth hormone-responsive serpin mRNAs in perinatal rat liver.
- Growth hormone induction of hepatic serine protease inhibitor 2.1 transcription is mediated by a Stat5-related factor binding synergistically to two gamma-activated si...
- Inhibition of growth hormone action in models of inflammation.
- Yin-yang 1 and glucocorticoid receptor participate in the Stat5-mediated growth hormone response of the serine protease inhibitor 2.1 gene.
- Growth hormone action in hypothyroid infant rats.
- Regulation of Spi 2.1 and 2.2 gene expression after turpentine inflammation: discordant responses to IL-6.
- Definition of a high affinity growth hormone DNA response element.
- Predictive value of plasma catecholamine levels in neonatal detection of Menkes disease.
- Single central incisor in familial holoprosencephaly.
- Neuroblastoma in a patient with Sotos'' syndrome.
- Outcome of pyruvate dehydrogenase deficiency treated with ketogenic diets. Studies in patients with identical mutations.
- Cockayne syndrome: review of 140 cases.
- Jarcho-Levin syndrome: four new cases and classification of subtypes.
- Retroviral-mediated transfer of the iduronate-2-sulfatase gene into lymphocytes for treatment of mild Hunter syndrome (mucopolysaccharidosis type II).
- Klippel-Trenaunay syndrome.
- Brain anomalies, retardation of mentality and growth, ectodermal dysplasia, skeletal malformations, Hirschsprung disease, ear deformity and deafness, eye hypoplasia, c...
- Mosaicism for deletion 1p36.33 in a patient with obesity and hyperphagia.
- Duplication of 7p: further delineation of the phenotype and restriction of the critical region to the distal part of the short arm.
- Mutations in transcriptional regulator ATRX establish the functional significance of a PHD-like domain.
- CBFA1 mutation analysis and functional correlation with phenotypic variability in cleidocranial dysplasia.
- Six new mutations in the ornithine transcarbamylase gene detected by single-strand conformational polymorphism.
- Partial monosomy of chromosome 1p36.3: characterization of the critical region and delineation of a syndrome.
- Partial methylcrotonyl-coenzyme A carboxylase deficiency in an infant with failure to thrive, gastrointestinal dysfunction, and hypertonia.
- Paris-Trousseau syndrome platelets in a child with Jacobsen's syndrome.
- Tyrosinase inhibition due to interaction of homocyst(e)ine with copper: the mechanism for reversible hypopigmentation in homocystinuria due to cystathionine beta-synth...
- Clinical and biochemical heterogeneity in females of a large pedigree with ornithine transcarbamylase deficiency due to the R141Q mutation.
- Infant with multiple congenital anomalies and deletion (9)(q34.3).
- Cardiac conduction improvement in two heterozygotes for primary carnitine deficiency on L-carnitine supplementation.
- The inborn errors of metabolism information system: A project of the Region 4 Genetics Collaborative Priority 2 Workgroup.
- Exome sequencing identifies ACSF3 as a cause of combined malonic and methylmalonic aciduria.
Schools
University of Kansas School of Medicine
University Of Minnesota
Doctors Specialties
- Clinical Genetics
- Pediatrics
- Medical Genetics
Accepted Insurances
- Choice Plus POS II
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- Blue Cross Accord
- CHAMPVA
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- Coventry Health Care
- First Health (Coventry Health Care) PPO
- Group Health Cooperative
- Choice Care PPO
- Medica
- Medicaid
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Tricare
- Choice Plus POS
- Navigate POS
- Options PPO
- United Healthcare
Awards
- Super Doctor
Education
-
University of Minnesota -
University of Kansas School of Medicine
Hospital
-
University of Minnesota Medical Center, Fairview
Drug Facts
| NPI NUMBER | 1982640264 | |
| NPPES Provider LastName | BERRY | |
| NPPES Provider FirstName | SUSAN | |
| NPPES Provider ZIPCode | 55455 | |
| NPPES Provider State | MN | |
| Specialty Description | Pediatric Medicine | |
| Total Claim Count | 94.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1982640264 |
| Last Name Of The Provider | BERRY |
| First Name Of The Provider | SUSAN |
| View All |
Similar Doctors
|
|
Dr. Kelly J. Ishizuka, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Debra D. Johnson, MD |
|
|
Dr. David J. Tilstra, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Aaron K. Graumann, MD |
|
|
Dr. Lisa A. Schimmenti, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard A. King, MD |
|
|
Dr. Aarti D. Bhatt, MD |
|
|
Dr. Bernard E. Trappey, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mary Ella M. Pierpont, MD |
|
|
Dr. Sarah L. Dugan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rhonda V. Liebo, MD |
|
|
Dr. Ronald C. McGlennen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Orit S. Reish, MD |
|
|
Karen N. Buser |